In Evaluate’s recently released annual World Preview Report, including updated global pharmaceutical market projections ...

Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation ...

J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled that Angelini has fallen short of its standards by ...

Whilst the NHS indubitably runs on international talent, however, this does not stop our system from pushing overseas nurses ...

Novo Nordisk has just released the topline findings from two eagerly anticipated phase 3 trials of its oral formulation of ...

Eli Lilly has become the first pharma group to reach a value of more than $1 trillion, joining a select group of companies ...

The positive result in OCEANIC-STROKE means that asundexian can potentially now sit alongside prostate cancer therapy Nubeqa (darolutamide) and kidney disease treatment Kerendia (finerenone) as a near ...

At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura, a ...

With new technologies that allow drugs to be tested directly in human biological systems, researchers are beginning to ...

At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial ...

A recent scientific preprint published by Paradromics reported that the Connexus implant – a tiny device that is implanted ...